Clinical trial · Interventional
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
Thulium Fiber Laser (TFL) Versus MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors: A Randomized Controlled Clinical Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Urolithiasis of Bladder | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MOSES holmium laser | Device | — | UNRESOLVED |
| TFL | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Thulium Fibre Laser
- description
- Participants randomized to this arm will undergo bladder resection using the TFL laser
- interventionNames
- Device: TFL
- type
- ACTIVE_COMPARATOR
- label
- MOSES Holmonium
- description
- Participants randomized to this arm will undergo bladder resection using the MOSES holmium laser.
- interventionNames
- Device: MOSES holmium laser
Primary outcomes (2)
- measure
- Presence of muscularis propria
- timeFrame
- 1 day post-procesure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Over 18 years of age at the time of enrollment. 2. Patients presented with visual criteria suggesting bladder tumor by outpatient cystoscopy will be legible for inclusion. Exclusion Criteria: 1. Tumors deemed not eligible for laser resection as determined by the Urologist e.g. obvious muscle-invasive or metastatic at presentation 2. Synchronous either urethral tumors or upper urinary tract tumor 3. History of Carcinoma in situ 4. Contracted bladder
References
Publications (0)
Data not yet available